Navamedic ASA (NAVA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Navamedic ASA (NAVA) has a cash flow conversion efficiency ratio of 0.019x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr5.69 Million ≈ $598.86K USD) by net assets (Nkr306.09 Million ≈ $32.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Navamedic ASA (NAVA) total market value for the company's overall valuation and market capitalisation.
Navamedic ASA - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Navamedic ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Navamedic ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Navamedic ASA ranked by their cash flow conversion efficiency. Explore NAVA cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Risma Systems AS
CO:RISMA
|
0.209x |
|
ContextVision AB
OL:CONTX
|
0.047x |
|
Dr Peng Telecom and Media Group Co Ltd
SHG:600804
|
-0.566x |
|
Tamul Multimedia Co. Ltd
KQ:093640
|
-0.041x |
|
American West Metals Ltd
AU:AW1
|
1.581x |
|
DONGJIANG ENVIRONMENTAL H
F:DGN
|
N/A |
|
Network-1 Technologies Inc
NYSE MKT:NTIP
|
-0.003x |
|
Chow Steel Industries Public Company Limited
BK:CHOW
|
0.041x |
Annual Cash Flow Conversion Efficiency for Navamedic ASA (2003–2025)
The table below shows the annual cash flow conversion efficiency of Navamedic ASA from 2003 to 2025. View today's stock price for Navamedic ASA for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr334.08 Million ≈ $35.15 Million |
Nkr25.59 Million ≈ $2.69 Million |
0.077x | -53.21% |
| 2024-12-31 | Nkr240.44 Million ≈ $25.30 Million |
Nkr39.35 Million ≈ $4.14 Million |
0.164x | +1570.51% |
| 2023-12-31 | Nkr222.39 Million ≈ $23.40 Million |
Nkr2.18 Million ≈ $229.29K |
0.010x | -88.55% |
| 2022-12-31 | Nkr209.72 Million ≈ $22.07 Million |
Nkr17.94 Million ≈ $1.89 Million |
0.086x | +1095.23% |
| 2021-12-31 | Nkr151.24 Million ≈ $15.91 Million |
Nkr-1.30 Million ≈ $-136.80K |
-0.009x | +65.00% |
| 2020-12-31 | Nkr129.49 Million ≈ $13.63 Million |
Nkr-3.18 Million ≈ $-334.63K |
-0.025x | -115.29% |
| 2019-12-31 | Nkr79.23 Million ≈ $8.34 Million |
Nkr12.72 Million ≈ $1.34 Million |
0.161x | +144.27% |
| 2018-12-31 | Nkr99.32 Million ≈ $10.45 Million |
Nkr-36.02 Million ≈ $-3.79 Million |
-0.363x | -159.37% |
| 2017-12-31 | Nkr96.70 Million ≈ $10.18 Million |
Nkr59.07 Million ≈ $6.22 Million |
0.611x | +545.20% |
| 2016-12-31 | Nkr105.73 Million ≈ $11.13 Million |
Nkr-14.51 Million ≈ $-1.53 Million |
-0.137x | -171.72% |
| 2015-12-31 | Nkr118.28 Million ≈ $12.45 Million |
Nkr22.63 Million ≈ $2.38 Million |
0.191x | +297.98% |
| 2014-12-31 | Nkr111.23 Million ≈ $11.70 Million |
Nkr-10.75 Million ≈ $-1.13 Million |
-0.097x | +33.78% |
| 2013-12-31 | Nkr107.26 Million ≈ $11.29 Million |
Nkr-15.65 Million ≈ $-1.65 Million |
-0.146x | -117.92% |
| 2012-12-31 | Nkr96.68 Million ≈ $10.17 Million |
Nkr-6.47 Million ≈ $-681.19K |
-0.067x | -6435.86% |
| 2011-12-31 | Nkr93.24 Million ≈ $9.81 Million |
Nkr-95.52K ≈ $-10.05K |
-0.001x | +99.24% |
| 2010-12-31 | Nkr100.21 Million ≈ $10.54 Million |
Nkr-13.46 Million ≈ $-1.42 Million |
-0.134x | -811.95% |
| 2009-12-31 | Nkr111.78 Million ≈ $11.76 Million |
Nkr-1.65 Million ≈ $-173.31K |
-0.015x | +84.76% |
| 2008-12-31 | Nkr110.24 Million ≈ $11.60 Million |
Nkr-10.66 Million ≈ $-1.12 Million |
-0.097x | -324.44% |
| 2007-12-31 | Nkr128.99 Million ≈ $13.57 Million |
Nkr5.56 Million ≈ $584.83K |
0.043x | +124.42% |
| 2006-12-31 | Nkr60.87 Million ≈ $6.40 Million |
Nkr-10.74 Million ≈ $-1.13 Million |
-0.176x | -144.73% |
| 2005-12-31 | Nkr43.19 Million ≈ $4.54 Million |
Nkr-3.11 Million ≈ $-327.70K |
-0.072x | +62.10% |
| 2004-12-31 | Nkr19.03 Million ≈ $2.00 Million |
Nkr-3.62 Million ≈ $-381.04K |
-0.190x | +68.79% |
| 2003-12-31 | Nkr7.21 Million ≈ $758.70K |
Nkr-4.40 Million ≈ $-462.53K |
-0.610x | -- |
About Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. The company offers medical nutrition… Read more